Abstract
Objective:
This study was performed to investigate the dose–response effects of supplementation with Bifidobacterium animalis subsp lactis (BB-12) and Lactobacillus paracasei subsp paracasei (CRL-431) on blood lipids, recovery from feces and bowel habits. Changes of the fecal microflora was analyzed in the 1010 CFU/day probiotic and placebo group.
Design:
The study was designed as a randomized, placebo-controlled, double-blinded, parallel dose–response study.
Subjects:
Healthy young adults (18–40 years) were recruited by advertising in local newspapers. Of the 75 persons enrolled, 71 (46 women, 25 men, mean age 25.6 years (range 18–40 years)) completed the study.
Intervention:
The volunteers were randomly assigned into five groups receiving either placebo or a mixture of the two probiotics in the concentration of 108, 109, 1010 or 1011 CFU/day in 2 weeks run-in period, 3 weeks intervention and 2 weeks wash-out. Diary reporting bowel habits and well being (abdominal bloating, flatulence and headache) was kept for all 7 weeks and blood lipids, fecal recovery of BB-12 and CRL-431, as well as fecal microflora was tested before, immediately and 2 weeks after intervention.
Results:
The fecal recovery of BB-12 increased significantly (P<0.001) with increasing dose. In the group receiving 1011 CFU/day BB-12 was recovered from 13 out of 15 volunteers. CRL-431 was not recovered in any of the fecal samples. Supplementation with probiotics did not change the fecal bacterial composition. A significant linear increase in fecal consistency (looser stool) with increasing probiotic dose (P=0.018) was observed. No overall dose–response effect was found on the blood lipids. High doses of probiotics were well tolerated.
Conclusion:
A dose-related recovery of BB-12 from feces was observed.
Sponsorship:
The study was sponsored by Chr. Hansen A/S, Hoersholm, Denmark.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.ejcn.1602450/MediaObjects/41430_2006_Article_BF1602450_Fig1_HTML.gif)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.ejcn.1602450/MediaObjects/41430_2006_Article_BF1602450_Fig2_HTML.gif)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.ejcn.1602450/MediaObjects/41430_2006_Article_BF1602450_Fig3_HTML.jpg)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.ejcn.1602450/MediaObjects/41430_2006_Article_BF1602450_Fig4_HTML.jpg)
Similar content being viewed by others
References
Abd El-Gawad IA, El-Sayed EM, Hafez SA, El-Zeini HM, Saleh FA (2005). The hypocholesterolaemic effects of milk yoghurt and soy-yoghurt containing bifidobacteria in rats fed on a cholesterol enriched diet. Int Dairy J 15, 37–44.
Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A (2000a). The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr 54, 856–860.
Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A (2000b). Effects of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 54, 288–297.
Alm L, Ryd-Kjellen E, Setterberg G, Blomquist L (1993). Effect of a new fermented milk product ‘CULTURA’ on constipation in geriatric patients. First Lactic Acid Bacteria Computer Conference Proceedings. Horizon Scientific Press, Norfolk, UK.
Anderson JW, Gilliland SE (1999). Effects on fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 18, 43–50.
Apajalahti JHA, Kettunen A, Nurminen PH, Jatila H, Holben WE (2003). Selective plating underestimates abundance and shows differential recovery of bifidobacterial species from human feces. Appl Environ Microbiol 69, 5731–5735.
Beimfohr C, Krause A, Amann R, Ludwig W, Schleifer K-H (1993). In situ identification of lactococci, enterococci and streptococci. Syst Appl Microbiol 16, 450–456.
Blum S, Schiffrin EJ (2003). Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Curr Issues Intestinal Microbiol 4, 53–60.
Brashears MM, Gilliland SE, Buck LM (1998). Bile salt deconjugation and cholesterol removal from media by Lactobacillus casei. J Dairy Sci 81, 2103–2110.
Charteris WP, Kelly PM, Morelli L, Collins JK (1998). Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract. Lett Appl Microbiol 26, 333–337.
Chouraqui J-P, Van Egroo L-D, Fichot M-C (2004). Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Ped Gastroent Nutr 38, 288–292.
Christensen HR, Larsen CN, Kæstel P, Rosholm L, Sternberg C, Michaelsen KF et al. (2006). Immunomodulatory potential of supplementation with probiotics: A dose-response study in healthy young adults. FEMS Immunol Med Microbiol, in press.
Dean BB, Borenstein JE, Henning JM, Knight K, Merz NB (2004). Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk? Am Heart J 147, 966–976.
FAO/WHO (2002). Guidelines for the evaluation of probiotics in food. Joint working group report on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada April 30 and May 1.
Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 18, 499–509.
Fukushima Y, Li S-T, Hara H, Terada A, Mitsuoka T (1997). Effect of follow-up formula containing bifidobacteria on fecal flora and fecal metabolites in healthy children. Biosci Microflora 16, 65–72.
Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T (1998). Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 39–44.
Gaon D, Garmendia C, Murrielo NO, de Cucco Games A, Cerchio A, Quintas R et al. (2002). Effect of Lactobacillus strains (L. casei and L. acidophilus Cerela) on bacterial overgrowth-related chronic diarrhea. Medicina 62, 159–163.
Gill HS, Rutherfurd KJ (2001). Probiotic supplementation to enhance natural immunity in the elderly: effects of a newly characterized immunostimulatory strain Lactobacillus rhamnosus HN001 (DR20(TM)) on leucocyte phagocytosis. Nutr Res 21, 183–189.
Gonzalez S, Albarracin G, Locascio de Ruiz Pesce M, Male M, Apella MC, Pesce de Ruiz Holgado A et al. (1990). Prevention of infantile diarrhea by fermented milk. Microbiologie-Aliments-Nutrition 8, 349–354.
Gonzalez SN, Apella MC, Romero NC, Nader De Macias ME, Oliver G (1993). Inhibition of enteropathogens by lactobacilli strains used in fermented milk. J Food Prot 56, 773–776.
Gonzalez S, Cardozo R, Apella M, Oliver G (1995). Biotherapeutic role of fermented milk. Biotherapy 8, 129–134.
Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P et al. (2004). Modulation of human dendritic cell phenotype by probiotic bacteria. Gut 53, 1602–1609.
Heaton KW, Thompson WG (1999). Diagnosis. In: Grant Thompson W, Heaton KW (eds). Irritable Bowel Syndrome. Health press: Oxford, 27.
Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S (2000). Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604–1610.
Kalliomäki M, Salminen S, Arvillommi H, Kero P, Koskinen P, Isolauri E (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076–1079.
Kalliomäki M, Salminen S, Poussa T, Arvillommi H, Isolauri E (2003). Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869–1871.
Kiessling G, Schneider J, Jahreis G (2002). Long term consumption of fermented diary products over 6 month increases HDL cholesterol. Eur J Clin Nutr 56, 843–849.
Kirjavainen PV, Arvola T, Salminen S, Isolauri E (2002). Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51, 51–55.
Klaver F, van der Meer R (1993). The assumed assimilation of cholesterol by lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating cativity. Appl Environ Microbiol 59, 1120–1124.
Laake KO, Bjorneklett A, Bakka A, Midtvedt T, Norin KE, Eide TJ et al. (1999). Influence of fermented milk on clinical state, fecal bacterial counts and biochemical characteristics in patients with ileal- pouch- anal-anastomosis. Microb Ecol Health Dis 11, 211–217.
Langhendries JP, Detry J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ et al. (1995). Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 21, 177–181.
Lewis SJ, Burmeister S (2005). A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. Eur J Clin Nutr 59, 776–780.
Lim KS, Huh CS, Baek YJ (1993). Antimicrobial susceptibility of bifidobacteria. J Dairy Sci 76, 2168–2174.
Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M et al. (2002). Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 16, 587–593.
Munoa FJ, Pares R (1988). Selective medium for isolation and enumeration of Bifidobacterium spp. Appl Environ Microbiol 54, 1715–1718.
Pereira DI, Gibson GR (2002). Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68, 4689–4693.
Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen D, Valerius NH et al. (2003). Effects of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111, 389–395.
Rosenfeldt V, Benfeldt E, Valerius N, Pærregaard A, Michaelsen KF (2004). Effects of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 145, 612–616.
Saavedra J, Abi-Hanna A, Moore N, Yolken R (1998). Effect of long term consumption of infant formulas with bifidobacteria and S. thermophilus on stool patterns and diaper rash in infants. J Pediatr Gastroenterol Nutr 27, 483.
Saavedra JM, Abi-Hanna A, Moore N, Yolken RH (2004). Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79, 261–267.
Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344, 1046–1049.
Saxelin M, Pessi T, Salminen S (1995). Fecal recovery following oral administration of Lactobacillus Strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol 25, 199–203.
Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A (1995). Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491–497.
Stahl DA, Devereux R, Amann RI, Flesher B, Lin C, Stromley J (1989). Ribosomal RNA based studies of natural microbial diversity and ecology. In: Hattori T, Ishida Y, Maruyama Y, Morita R, Uchida A (eds). Recent Advances in Microbial Ecology. Japan Scientific Societies Press: Tokyo, Japan, pp 669–673.
Szajewska H, Mrukowicz J (2001). Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic rewiev of published, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33, S17–S25.
Tahri K, Grill PJ, Schneider F (1996). Bifidobacteria strain behavior towards cholesterol:coprecipitation with bile salts and assimilation. Curr Microbiol 33, 187–193.
Tanaka H, Doesburg K, Iwaski T, Mierau I (1999). Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 82, 2530–2535.
Tannock GW (2002). Analysis of the intestinal microflora using molecular methods. Eur J Clin Nutr 56 (Suppl 4), S44–S49.
Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K (2004). Colonization and immunomodulation by Lactobacillus reuteri ATCC55730 in the human gastrointestinal tract. Appl Environ Microbiol 70, 1176–1181.
Van Niel CW, Feudtner C, Garrison MM, Christakis DA (2002). Lactobacillus therapy for acute infectious diarrhea in children: A meta-analysis. Pediatrics 109, 678–684.
Weizman Z, Asli G, Alsheikh A (2005). Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115, 5–9.
Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A et al. (2003). Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86, 2452–2461.
Acknowledgements
The skillful technical assistance of Abdallah Albayasli, Helle Schack Andersen, Karin Schlichter, Rita Lohmann and Susanne Stoeving Jensen is highly appreciated. The study was financed by Chr. Hansen A/S.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantor: KF Michaelsen.
Contributors: DCE, CNL and KFM wrote the protocol. DCE performed the study. CNL did the microbiological analysis of fecal samples and study product. EB performed the fluorescent whole cell hybridization of BB-12 like colonies. MB performed the PFGE of CRL-431 like colonies. PK performed the statistical analysis. CNL and SN wrote the first draft of the paper and all contributors participated in the revision and final approval of the paper.
Rights and permissions
About this article
Cite this article
Larsen, C., Nielsen, S., Kæstel, P. et al. Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 60, 1284–1293 (2006). https://doi.org/10.1038/sj.ejcn.1602450
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602450
Keywords
This article is cited by
-
Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial
Scientific Reports (2020)
-
Probiotics and Gut Health in Athletes
Current Nutrition Reports (2020)
-
Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population
European Journal of Nutrition (2019)
-
Daily consumption of a synbiotic yogurt decreases energy intake but does not improve gastrointestinal transit time: a double-blind, randomized, crossover study in healthy adults
Nutrition Journal (2013)
-
Lactobacillus paracasei subsp. paracasei LC01 positively modulates intestinal microflora in healthy young adults
Journal of Microbiology (2013)